Agenus | Passifs Courants





Passifs Courants Changement Date
AbbVie USD 39.39B 376M 2025-09
Agenus USD 287.13M 52.57M 2025-09
Amgen USD 25.49B 3.7B 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Celldex Therapeutics USD 46.46M 13.5M 2025-09
CSL USD 4.82B 1.26B 2025-06
Dynavax Technologies USD 106.84M 11.39M 2025-09
Eli Lilly USD 40.14B 1.12B 2025-09
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Glaxosmithkline GBP 28.68B 8.3B 2025-09
Incyte USD 1.52B 176.44M 2025-12
Intrexon USD 23.02M 38K 2024-06
J&J USD 50.87B 3.31B 2025-09
Jiangsu Hengrui CNY 7.85B 4.39B 2025-09
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
MacroGenics USD 44.47M 5.47M 2025-09
Merck EUR 8.64B 1.22B 2025-09
Merck USD 28.63B 2.59B 2025-09
Novartis USD 32B 286M 2025-09
Novavax USD 429.87M 40.73M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Veracyte USD 72.15M 4.28M 2025-09


Agenus Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.